Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs MARKSANS PHARMA. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES MARKSANS PHARMA. ZIM LABORATORIES/
MARKSANS PHARMA.
 
P/E (TTM) x 36.0 23.8 151.2% View Chart
P/BV x 2.9 4.4 67.5% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 ZIM LABORATORIES   MARKSANS PHARMA.
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-23
MARKSANS PHARMA.
Mar-23
ZIM LABORATORIES/
MARKSANS PHARMA.
5-Yr Chart
Click to enlarge
High Rs38874 521.4%   
Low Rs6739 174.3%   
Sales per share (Unadj.) Rs81.840.9 200.1%  
Earnings per share (Unadj.) Rs5.05.9 85.6%  
Cash flow per share (Unadj.) Rs8.67.0 122.9%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %00.9 0.0%  
Book value per share (Unadj.) Rs41.138.5 106.8%  
Shares outstanding (eoy) m48.73453.16 10.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.81.4 201.2%   
Avg P/E ratio x45.49.7 470.1%  
P/CF ratio (eoy) x26.58.1 327.7%  
Price / Book Value ratio x5.51.5 377.1%  
Dividend payout %08.5 0.0%   
Avg Mkt Cap Rs m11,09625,631 43.3%   
No. of employees `000NANA-   
Total wages/salary Rs m4932,394 20.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,98518,521 21.5%  
Other income Rs m64593 10.8%   
Total revenues Rs m4,04919,115 21.2%   
Gross profit Rs m5203,393 15.3%  
Depreciation Rs m175519 33.7%   
Interest Rs m5691 61.1%   
Profit before tax Rs m3543,377 10.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m109723 15.1%   
Profit after tax Rs m2442,653 9.2%  
Gross profit margin %13.018.3 71.2%  
Effective tax rate %30.921.4 144.2%   
Net profit margin %6.114.3 42.8%  
BALANCE SHEET DATA
Current assets Rs m1,90916,997 11.2%   
Current liabilities Rs m1,1083,654 30.3%   
Net working cap to sales %20.172.0 27.9%  
Current ratio x1.74.7 37.0%  
Inventory Days Days196 341.6%  
Debtors Days Days87282 1,061.9%  
Net fixed assets Rs m1,5695,246 29.9%   
Share capital Rs m487453 107.5%   
"Free" reserves Rs m1,51616,998 8.9%   
Net worth Rs m2,00317,452 11.5%   
Long term debt Rs m2460-   
Total assets Rs m3,47922,242 15.6%  
Interest coverage x7.338.0 19.3%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.10.8 137.6%   
Return on assets %8.612.3 69.9%  
Return on equity %12.215.2 80.2%  
Return on capital %18.219.9 91.6%  
Exports to sales %81.10-   
Imports to sales %12.27.3 167.3%   
Exports (fob) Rs m3,230NA-   
Imports (cif) Rs m4851,348 36.0%   
Fx inflow Rs m3,2816,491 50.5%   
Fx outflow Rs m4851,348 36.0%   
Net fx Rs m2,7965,143 54.4%   
CASH FLOW
From Operations Rs m3752,374 15.8%  
From Investments Rs m-362-2,592 14.0%  
From Financial Activity Rs m51,978 0.3%  
Net Cashflow Rs m301,760 1.7%  

Share Holding

Indian Promoters % 33.3 43.9 75.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 20.7 0.0%  
FIIs % 0.0 15.6 0.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 56.2 118.9%  
Shareholders   17,100 254,699 6.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ZIM LABORATORIES vs MARKSANS PHARMA.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ZIM LABORATORIES vs MARKSANS PHARMA. Share Price Performance

Period ZIM LABORATORIES MARKSANS PHARMA. S&P BSE HEALTHCARE
1-Day 8.86% -0.89% 1.03%
1-Month 25.00% 16.51% 1.10%
1-Year 55.03% 110.57% 53.75%
3-Year CAGR 6.85% 34.97% 14.67%
5-Year CAGR -0.96% 47.26% 19.26%

* Compound Annual Growth Rate

Here are more details on the ZIM LABORATORIES share price and the MARKSANS PHARMA. share price.

Moving on to shareholding structures...

The promoters of ZIM LABORATORIES hold a 33.3% stake in the company. In case of MARKSANS PHARMA. the stake stands at 43.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ZIM LABORATORIES and the shareholding pattern of MARKSANS PHARMA..

Finally, a word on dividends...

In the most recent financial year, ZIM LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

MARKSANS PHARMA. paid Rs 0.5, and its dividend payout ratio stood at 8.5%.

You may visit here to review the dividend history of ZIM LABORATORIES, and the dividend history of MARKSANS PHARMA..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 114 Points Higher | Metal Stocks Shine | VI Tanks 9% Sensex Today Ends 114 Points Higher | Metal Stocks Shine | VI Tanks 9%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.